chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: U
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: Aching; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (159558).  A patient (no qualifiers provided) received bnt162b2 (BNT162B2), administration date 16Aug2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN (non-serious) with onset Aug2021, outcome "unknown", described as "Aching".  Additional information: The patient will have dental appointment after 2 days. Dental appointment and it was like for the paining and, but the patient was given the premedication antibiotic Amoxicillin so they wanted to ask if this will have any issues with the Pfizer vaccine. It was given to the patient as a pre medication but not has been taken yet. The reporter wanted to know if it's gonna be okay with the vaccine since the dental appointment would be 18Aug2021 and Amoxicillin should be taken before that dental appointment.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 71.0
Sex: U
Vaccine: COVID19
Symptoms: Sleep apnoea syndrome
Clinical narrative: Last night I sleep by myself and I stop breathing; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 71 year-old patient received bnt162b2 (BNT162B2), administered in arm left, administration date 16Aug2021 (Lot number: FC3180) at the age of 71 years as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: SLEEP APNOEA SYNDROME (non-serious) with onset Aug2021, outcome "unknown", described as "Last night I sleep by myself and I stop breathing".  Additional information: Patient is scheduled for the second dose three weeks from the days given. Patient did not have any investigational Assessment till now, however will be having lab work (blood work) today.  Follow-up attempts are completed. No further information is expected.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Illness, Magnetic resonance imaging, Nausea
Clinical narrative: felt a little funny; felt a little queasy and sick; felt a little queasy and sick; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 78 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 12Feb2021 (Lot number: EL9L66) at the age of 77 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: FEELING ABNORMAL (non-serious), outcome "unknown", described as "felt a little funny"; ILLNESS (non-serious), NAUSEA (non-serious), outcome "unknown" and all described as "felt a little queasy and sick". Relevant laboratory tests and procedures are available in the appropriate section.  Additional information:The first shot she felt a little funny towards the end of the day and felt a little queasy and sick and the next day was fine but it was not one to write home about.  No follow-up attempts are possible. No further information is expected.
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Dysgeusia
Clinical narrative: I am having a metallic taste; still I am not having the normal taste; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 40 year-old male patient received bnt162b2 (BNT162B2), administration date 24May2021 (Lot number: EW0186) at the age of 40 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. Vaccination history included: Bnt162b2 (First dose vaccination date: 03May2021, First dose vaccine LOT#EW0170."), administration date: 03May2021, when the patient was 39 years old, for Covid-19 Immunization. The following information was reported: DYSGEUSIA (non-serious), outcome "not recovered", described as "I am having a metallic taste; still I am not having the normal taste". Therapeutic measures were not taken as a result of dysgeusia.  Additional Information: The consumer asked to whom he needs to contact to get the solution for that (metallic taste) because still he was not having the normal taste, he found 2 trained Doctors, but they were also not sure about that. Consumer was informed about Pfizer Medical Information Department.  No follow-up attempts are possible. No further information is expected.
Age: 15.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Eye pain, Headache
Clinical narrative: Headaches; his eye was hurting when he looks up; Chills; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the parent.  A 15 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 16Aug2021 (Lot number: FA7485, Expiration Date: Oct2021) at the age of 15 years as dose 2, 0.3 ml single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Vaccine Name: First dose of the COVID vaccine, Lot Number / Expiry Date: FA7484/ Sep2021, Route, Anatomical Location:  Left arm, No. of Previous Doses: This was dose 1 of 2. , Date: 26Jul2021), administration date: 26Jul2021, when the patient was 15 years old, for COVID-19 immunisation. The following information was reported: HEADACHE (non-serious), outcome "unknown", described as "Headaches"; EYE PAIN (non-serious), outcome "unknown", described as "his eye was hurting when he looks up"; CHILLS (non-serious), outcome "unknown", described as "Chills".  Follow-up attempts are completed. No further information is expected.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache
Clinical narrative: Chills; headache; exhaustion; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 52 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 17Aug2021 01:00 (Lot number: F(318) at the age of 52 years as dose number unknown, single for covid-19 immunisation. Relevant medical history included: "Invasive breast cancer" (unspecified if ongoing). Concomitant medication(s) included: TAMOXIFEN; VENLAFAXINE; CALCIUM; VITAMIN D NOS. The following information was reported: CHILLS (non-serious) with onset 18Aug2021 07:00, outcome "not recovered", described as "Chills"; HEADACHE (non-serious) with onset 18Aug2021 07:00, outcome "not recovered", described as "headache"; FATIGUE (non-serious) with onset 18Aug2021 07:00, outcome "not recovered", described as "exhaustion". Therapeutic measures were not taken as a result of chills, headache, fatigue.  Additional information: Patient did not receive any other vaccine in four weeks. She received Tamoxifen, venlafaxine, calcium, vitamin D medications in two weeks. She did not have covid prior vaccination and did not test covid post vaccination. No Known allergies.  Follow-up attempts are completed. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: sore arm; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), administration date 12Feb2021 (Lot number: EN6201) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose 1, Lot number: EL8982), administration date: 20Jan2021, for COVID-19 immunization. The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "sore arm".  Additional information: The caller said that they were both fully vaccinated. The caller mentioned that they had a sore arm and that was the biggest side effect that they had.    No follow-up attempts are possible. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101068839 same product and event, different patients
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Antibody test, Pain in extremity
Clinical narrative: sore arm; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP).  A 62 year-old male patient received bnt162b2 (BNT162B2), administered in arm right, administration date 12Feb2021 (Lot number: EN6201) at the age of 62 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Type 2 diabetes mellitus" (ongoing), notes: Diagnosed within the last 5 years; "High blood pressure" (unspecified if ongoing), notes: Investigation Assessment: Yes; "High cholesterol" (unspecified if ongoing). Concomitant medication(s) included: METFORMIN taken for type 2 diabetes mellitus; TELMISARTAN; PRAVASTATIN taken for blood cholesterol increased; VITAMIN C ACID taken for supplementation therapy; VITAMIN D3 taken for supplementation therapy. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE, Time the Vaccination Was Given: between 14:00-15:00, Batch number: EL8982, manufacturer: Pfizer, Anatomical Location of Administration :Right arm), administration date: 20Jan2021, when the patient was 62 years old, for Covid-19 immunisation. The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "sore arm". The event "sore arm" was evaluated at the physician office visit. Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: She said that recently they went to have their antibodies tested, her husband is coming up with no antibodies on the quick test. They are saying that he does not have any antibodies. Does he need a booster? It is important to let Pfizer know. He has been tested twice. Once with a rapid test and the other was with a blood test through the physician's office. The second dose had to be defrosted and they had to wait to get the second vaccine. She said that they had to prepare it to be able to administer it at the clinic. She got vaccinated with the same lot numbers and she had strong antibodies, but he has diabetes and high blood pressure and has no antibodies. Time the Vaccination Was Given: between 2-3 in the afternoon for both doses. Emergency Room: No. Physician Office: Yes. Prior Vaccinations (within 4 weeks) If applicable, list any other vaccinations within four weeks prior to the first administration date of the suspect vaccine(s): None  No follow-up attempts are possible. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101068833 same product and event, different patients
Sex: F
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: Dizziness; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient.  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DIZZINESS (non-serious), outcome "unknown", described as "Dizziness".  Additional information: Reporter withheld said that sometime ago she called in about reporting a reaction which is Dizziness. Caller also mentioned that she received a questionnaire but she messed up on it and requested another one to submit to her Doctor. Caller provided her full name and while providing her address, the call got disconnected.    No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 58.0
Sex: U
Vaccine: COVID19
Symptoms: Hypoaesthesia, Somnolence
Clinical narrative: Currently both arms go numb; fall asleep while I am sleeping; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 58 year-old patient received bnt162b2 (BNT162B2), intramuscular, administered in deltoid left, administration date 22Dec2020 (Lot number: EK5730, Expiration Date: 31Mar2021) at the age of 58 years as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: HYPOAESTHESIA (non-serious), outcome "unknown", described as "Currently both arms go numb"; SOMNOLENCE (non-serious), outcome "unknown", described as "fall asleep while I am sleeping".  Additional information: Patient Prior Vaccination (within 4 weeks) was none. Patient concomitant drugs was none. Patient medical history was none. Patient relevant tests was none. Patient started Tylenol on 09Jan2021. Currently both patient arms go numb- fall asleep while patient was sleeping. This happens intermittently. Patient have never experienced the Frequency of both arms going numb before the vaccine.  Follow-up attempts are completed. No further information is expected.
Age: 70.0
Sex: U
Vaccine: COVID19
Symptoms: Asthenia, Balance disorder, Chills, Computerised tomogram, Fatigue
Clinical narrative: nausea; headache; chills; balance problems; weakness; I became extremely fatigued which continued through my second vaccine; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 70 year-old patient received bnt162b2 (BNT162B2), administered in arm right, administration date 07Apr2021 12:30 (Lot number: EP8730) at the age of 70 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. Vaccination history included: Bnt162b2 (Dose: 1, Date: 10Mar2021, Time: 10:15 , Anatomical Site of injection: Left arm, Batch/Lot number: EN6199), administration date: 10Mar2021, when the patient was 70 years old, for Covid-19 Immunization, reaction(s): "Extremely fatigued". The following information was reported: NAUSEA (non-serious) with onset 2021, outcome "not recovered", described as "nausea"; HEADACHE (non-serious) with onset 2021, outcome "not recovered", described as "headache"; CHILLS (non-serious) with onset 2021, outcome "not recovered", described as "chills"; BALANCE DISORDER (non-serious) with onset 2021, outcome "not recovered", described as "balance problems"; ASTHENIA (non-serious) with onset 2021, outcome "not recovered", described as "weakness"; FATIGUE (non-serious) with onset 2021, outcome "unknown", described as "I became extremely fatigued which continued through my second vaccine". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of balance disorder, asthenia.  Additional information: The patient did not receive any other vaccines within four weeks prior to the vaccination. After my first vaccine 10Mar2021 I became extremely fatigued which continued through my second vaccine on 07Apr2021. After second vaccine symptoms of nausea, headaches, chills, balance problems, weakness in legs became more severe. I now use a walker for balance and because of weakness I use it for support outside of my home. In closing hopefully this will provide some insight to others who are experiencing similar symptoms.  No follow-up attempts are possible. No further information is expected.
Age: 70.0
Sex: U
Vaccine: COVID19
Symptoms: Headache, Magnetic resonance imaging, Nausea
Clinical narrative: nausea; headache; chills; balance problems; weakness; I became extremely fatigued which continued through my second vaccine; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 70 year-old patient received bnt162b2 (BNT162B2), administered in arm right, administration date 07Apr2021 12:30 (Lot number: EP8730) at the age of 70 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. Vaccination history included: Bnt162b2 (Dose: 1, Date: 10Mar2021, Time: 10:15 , Anatomical Site of injection: Left arm, Batch/Lot number: EN6199), administration date: 10Mar2021, when the patient was 70 years old, for Covid-19 Immunization, reaction(s): "Extremely fatigued". The following information was reported: NAUSEA (non-serious) with onset 2021, outcome "not recovered", described as "nausea"; HEADACHE (non-serious) with onset 2021, outcome "not recovered", described as "headache"; CHILLS (non-serious) with onset 2021, outcome "not recovered", described as "chills"; BALANCE DISORDER (non-serious) with onset 2021, outcome "not recovered", described as "balance problems"; ASTHENIA (non-serious) with onset 2021, outcome "not recovered", described as "weakness"; FATIGUE (non-serious) with onset 2021, outcome "unknown", described as "I became extremely fatigued which continued through my second vaccine". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of balance disorder, asthenia.  Additional information: The patient did not receive any other vaccines within four weeks prior to the vaccination. After my first vaccine 10Mar2021 I became extremely fatigued which continued through my second vaccine on 07Apr2021. After second vaccine symptoms of nausea, headaches, chills, balance problems, weakness in legs became more severe. I now use a walker for balance and because of weakness I use it for support outside of my home. In closing hopefully this will provide some insight to others who are experiencing similar symptoms.  No follow-up attempts are possible. No further information is expected.
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Burning sensation, Full blood count, Gastrooesophageal reflux disease, Metabolic function test
Clinical narrative: GERD; burning sensation; This is a spontaneous report received from a contactable reporter(s) (Physician).  A 40 year-old male patient received bnt162b2 (BNT162B2), intramuscular, administration date 23Jul2021 14:17 (Lot number: EW0171) at the age of 40 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose: 1st, Time: 11:02 AM, Anatomical site of injection: Deltoid, Route of administration: Intramuscular, Batch/Lot number: EW0171), administration date: 29Apr2021, when the patient was 39 years old, for COVID-19 immunization, reaction(s): "Rash", "fatigue", "Chills", "extreme body heat", "Dry skin", "burning sensation in my arms and feet". The following information was reported: GASTROOESOPHAGEAL REFLUX DISEASE (non-serious) with onset 29Jul2021, outcome "unknown", described as "GERD"; BURNING SENSATION (non-serious) with onset 29Jul2021, outcome "unknown", described as "burning sensation". Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: The patient had not received any other vaccinations within 4 weeks.  No follow-up attempts are possible. No further information is expected.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: had a sore arm the evening of the first vaccine.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 68 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 02Apr2021 (Lot number: EP6955) as dose 1, single and administered in arm left, administration date 23Apr2021 (Lot number: EP7533) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Past drug history included: Hand sanitizer, reaction(s): "eczema", notes: Caller reports that he got eczema from using hand sanitizer.  The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 02Apr2021, outcome "recovered" (24Apr2021), described as "had a sore arm the evening of the first vaccine.".  Additional information: He reported he had a sore arm the evening of the first vaccine. The arm pain from the first shot lasted about a day. The arm pain after the second shot lasted about a day and a half. He stated that he only had a sore arm, that was all. Caller remarked that mostly everyone he know got a sore arm after the shot, like after getting a tetanus shot. Caller provided not other information regarding this statement. He wanted to know if there was a need for more doses/booster doses of the Pfizer Covid vaccine? He wanted to know more details on how someone was deemed immunocompromised in order to get a third dose of the vaccine. A third dose of the Pfizer-BioNTech COVID-19 vaccine (0.3 mL) administered at least 28 days following the first two doses of this vaccine was authorized for administration to individuals at least 12 years of age who have undergone solid organ transplantation, or who are diagnosed with conditions that are considered to have an equivalent level of immunocompromise."  No follow-up attempts are possible. No further information is expected.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Muscle spasms
Clinical narrative: Severe headaches every day; Muscle spasms; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 36 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 28Jul2021 17:00 (Lot number: Fa7404) at the age of 36 years as dose number unknown, single for covid-19 immunisation. Relevant medical history included: "Factor V" (unspecified if ongoing). The patient's concomitant medications were not reported.  The following information was reported: HEADACHE (non-serious) with onset 29Jul2021, outcome "not recovered", described as "Severe headaches every day"; MUSCLE SPASMS (non-serious) with onset 29Jul2021, outcome "not recovered", described as "Muscle spasms". The events "severe headaches every day" and "muscle spasms" were evaluated at the physician office visit. Therapeutic measures were not taken as a result of headache, muscle spasms.  Additional information: No covid prior to vaccination not tested for covid post vaccination. No known allergies. No other vaccines in four weeks.  No follow-up attempts are possible. No further information is expected.
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Haemorrhoids
Clinical narrative: Massive external Hemorrhoids three times in four months and NEVER had them before getting this vaccine and I am almost 60 years old with no family history of this.  Medications are unchanged for 12 mo; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 59 year-old male patient received bnt162b2 (BNT162B2) (Lot number: EW0102) at the age of 59 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Ventricular Tachycardia (I have an ICD)" (unspecified if ongoing), notes: Ventricular Tachycardia (I have an ICD). Concomitant medication(s) included: LEVOTHYROXINE SODIUM; BISOPROLOL. Past drug history included: Keflex, reaction(s): "Known Allergies", notes: Allergies: Keflex. Vaccination history included: Bnt162b2 (product=COVID 19, brand=Pfizer,, lot number=EW0170,, lot unknown=False,, administration date=22Apr2021,, administration time=02:00 PM,, dose number=1,, vaccine location=Left arm), administration date: 22Apr2021, when the patient was 59 years old, for Covid-19 immunization. The following information was reported: HAEMORRHOIDS (non-serious) with onset 04Jun2021, outcome "not recovered", described as "Massive external Hemorrhoids three times in four months and NEVER had them before getting this vaccine and I am almost 60 years old with no family history of this.  Medications are unchanged for 12 mo". Therapeutic measures were not taken as a result of haemorrhoids.  Additional Information: Facility type vaccine: Pharmacy or Drug Store. Adverse event: Massive external Hemorrhoids three times in four months and NEVER had them before getting this vaccine and he was almost 60 years old with no family history of this. Medications are unchanged for 12 months with no side affects. Only thing that changed since April was getting two doses three weeks apart of the Pfizer vaccine.  No follow-up attempts are possible. No further information is expected.
Age: 15.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Migraine, Pain
Clinical narrative: Chills; body aches; migraine; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 15 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 13Aug2021 05:15 (Lot number: Ew6169) at the age of 15 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Batch No: Ew6169), administration date: 2021, when the patient was 15 years old, for Covid-19 immunization. The following information was reported: CHILLS (non-serious) with onset 2021, outcome "recovered" (2021), described as "Chills"; PAIN (non-serious) with onset 2021, outcome "recovered" (2021), described as "body aches"; MIGRAINE (non-serious) with onset 2021, outcome "recovered" (2021), described as "migraine". No follow-up attempts are possible. No further information is expected.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site swelling
Clinical narrative: Injection site is large and swollen a little smaller than a tennis ball and growing everyday; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 34 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 15Aug2021 12:30 (Lot number: FD8448) at the age of 34 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Past drug history included: Benadryl; Niacin. Vaccination history included: Bnt162b2 (product=COVID 19 brand=Pfizer, lot number=FA7485, administration time=12:30 PM, dose number=1, vaccine location=Left arm), administration date: 25Jul2021, for Covid-19 immunization. The following information was reported: VACCINATION SITE SWELLING (non-serious) with onset Aug2021, outcome "not recovered", described as "Injection site is large and swollen a little smaller than a tennis ball and growing everyday". The event "injection site is large and swollen a little smaller than a tennis ball and growing everyday" was evaluated at the physician office visit. It was unknown if therapeutic measures were taken as a result of vaccination site swelling.  Additional information: The patient did not received any other vaccines within 4 weeks prior to the COVID vaccine, and received other medications in two weeks. Prior to vaccination, the patient diagnosed with COVID-19 and since the vaccination, the patient has not been tested for COVID-19.  Follow-up attempts are completed. No further information is expected.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Nausea, Pain in extremity, Tongue eruption
Clinical narrative: 2 rashes on tongue; sore arm; one hour after receiving it I got a minor headache; 6 hours after receiving it I felt nauseous; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 36 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 13Aug2021 16:00 (Lot number: FC3181) at the age of 36 years as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications.  The following information was reported: TONGUE ERUPTION (non-serious) with onset 13Aug2021 16:45, outcome "recovered" (Aug2021), described as "2 rashes on tongue"; HEADACHE (non-serious) with onset 13Aug2021, outcome "recovered" (Aug2021), described as "one hour after receiving it I got a minor headache"; NAUSEA (non-serious) with onset 13Aug2021, outcome "recovered" (Aug2021), described as "6 hours after receiving it I felt nauseous"; PAIN IN EXTREMITY (non-serious) with onset 13Aug2021 16:45, outcome "recovered" (Aug2021), described as "sore arm". Therapeutic measures were not taken as a result of tongue eruption, headache, nausea, pain in extremity.  Additional information: The patient did not received any other vaccines within 4 weeks prior to the COVID vaccine. Patient did not received other medication within 2 weeks of vaccination. The patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, the patient has not been tested for COVID-19. The patient dose not have any known allergy.  No follow-up attempts are possible. No further information is expected.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: She had a sore arm after the first dose; This is a spontaneous report received from a contactable reporter (Consumer or other non HCP) from medical information team. A 60 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 02Apr2021 (Lot number: EP6955) at the age of 60 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "She had a sore arm after the first dose".  Additional information: Caller reports that his fiancee/partner (name) 60 y/o female) received her Pfizer Covid vaccines the same dates he did. She had a sore arm after the first dose and had a 102-degree Fahrenheit temperature, migraine headache, and sore arm after the second dose.  No follow-up attempts are possible. No further information is expected.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Burning sensation, Feeling hot, Head discomfort, Musculoskeletal stiffness
Clinical narrative: I have a stiff neck but that may be from sleeping.; Three hours after receiving the vaccine I felt a burning sensation at the top of my head; The area of my head where it occurs has changed some but always around the very top of my head.; My whole scalp felt hot,; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 63 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 16Aug2021 12:00 (Lot number: FD8448) at the age of 63 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "hip replacement" (unspecified if ongoing); "Hypothyroidism" (unspecified if ongoing). Concomitant medication(s) included: SYNTHROID. Past drug history included: Codeine, reaction(s): "Known allergies codeine", notes: Codeine and sinus products over the counter. The following information was reported: MUSCULOSKELETAL STIFFNESS (non-serious) with onset 16Aug2021 15:00, outcome "not recovered", described as "I have a stiff neck but that may be from sleeping."; BURNING SENSATION (non-serious) with onset 16Aug2021 15:00, outcome "not recovered", described as "Three hours after receiving the vaccine I felt a burning sensation at the top of my head"; HEAD DISCOMFORT (non-serious) with onset 16Aug2021 15:00, outcome "not recovered", described as "The area of my head where it occurs has changed some but always around the very top of my head."; FEELING HOT (non-serious) with onset 16Aug2021 15:00, outcome "not recovered", described as "My whole scalp felt hot,". Therapeutic measures were not taken as a result of musculoskeletal stiffness, burning sensation, head discomfort. Therapeutic measures were taken as a result of feeling hot.  Additional information: Facility type vaccine was Pharmacy or Drug Store. If other vaccine in four weeks was no. Other medications in two weeks was Synthroid 1.15. It was reported that Three hours after receiving the vaccine I felt a burning sensation at the top of my head, it lasted only a few sections then stopped, it happened again 3 times that day. It felt like my blood pressure was up but it wasn't. The second day it happened again but not with the same burning sensation, it happened a couple of more times. This is the third day it has happened several more times but not as painful as the first day. The area of my head where it occurs has changed some but always around the very top of my head. My whole scalp felt hot, I placed an ice pack on it which felt better. I have a stiff neck but that may be from sleeping. My concern is my brain being affected in some way. If covid prior vaccination and If covid tested post vaccination was no.  Follow-up attempts are completed. No follow-up attempts are possible. No further information is expected.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Peripheral swelling
Clinical narrative: Swelling on her feet and hand; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 53 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 29Mar2021 13:45 (Lot number: ER8727) at the age of 53 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Asthma" (unspecified if ongoing), notes: Has had asthma since birth.; "Allergy" (unspecified if ongoing), notes: Caller states she has a lot of allergies to a lot of medications and food, no further details provided; "Type II diabetes mellitus" (unspecified if ongoing), notes: She was not diagnosed with this condition until maybe her late 20's; "Hypothyroidism" (unspecified if ongoing), notes: She states she was diagnosed with Grave's disease in her early 20's, she clarifies she had Grave's disease first.; "Grave's disease" (unspecified if ongoing), notes: She states she was diagnosed with Grave's disease in her early 20's, she clarifies she had Grave's disease first.; "Ruptured eardrum" (unspecified if ongoing); "Allergy" (unspecified if ongoing), notes: Caller states she has a lot of allergies to a lot of medications and food, no further details provided. Concomitant medication(s) included: DEXAMETH taken for tympanic membrane perforation, stop date: 29Mar2021. The following information was reported: PERIPHERAL SWELLING (non-serious) with onset 29Mar2021, outcome "unknown", described as "Swelling on her feet and hand".  Additional Context:  The callers states she is calling in regards to the Covid vaccine she received back in Mar2021 and Apr2021. She had a severe allergic reaction on the second shot and she knows they are know recommending a booster shot, but caller wants to know what is Pfizer's advice on getting the booster shot if she does decide to get it?The caller states she had a slight allergic reaction to the first dose of the COVID vaccine, but at the time she thought it was from eating something very salty for lunch. She clarifies she had swelling on her feet and hand. The swelling was not so bad on the first dose. She confirms she had the first dose on 29Mar2021 at 13:45. Probably within an hour of that, she started to experience the swelling. Caller states she saw a doctor a week before she was going to get her COVID shot and she asked if it was okay to get her COVID shot and she was told it was fine. She was prescribed an ear drop for a ruptured eardrum. She provides the following off of her bottle of Eardrops. No Additional Vaccines  was Administered on Same Date of the Pfizer Suspect. o ER visit require. No Prior Vaccinations (within 4 weeks). No family history reported. There was a product complaint (Caller was prescribed an ear drop for a ruptured eardrum. She provides the following off of her bottle of eardrops)  No follow-up attempts are possible. No further information is expected.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Moderate localized injection site muscle pain.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non-HCP). The reporter is the patient.  A 64-year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 18Aug2021 17:45 (Lot number: FC3181) at the age of 64 years as dose number unknown, single for covid-19 immunisation. Relevant medical history included: "known allergies: Yes" (unspecified if ongoing). The patient took concomitant medications.  The following information was reported: VACCINATION SITE PAIN (non-serious) with onset 19Aug2021 06:00, outcome "recovering", described as "Moderate localized injection site muscle pain.". Therapeutic measures were taken as a result of vaccination site pain.  Additional information: patient has not taken any other vaccine within four weeks. Treatment received with Acetaminophen w/caffeine.  Patient was not tested with covid-19 prior to vaccination and not been tested since the vaccination. Other medical history: I will provide if contacted. List too long for this form.  No follow-up attempts are possible. No further information is expected.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Breast tenderness, Eosinophil count increased, Full blood count, Lymphadenopathy
Clinical narrative: Swollen Lymph Nodes - under arms, both sides; Swollen Lymph Nodes - under arms, both sides, tender sides of breasts.; CBC blood test showed doubled levels of absolute eosinophils; This is a spontaneous report received from contactable reporter(s) (Consumer or other non-HCP). The reporter is the patient.  A 46-year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 16Jul2021 16:30 (Lot number: EW0170) at the age of 46 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Heart murmors" (unspecified if ongoing); "known allergies; Tetracyclins" (unspecified if ongoing). The patient took concomitant medications. The following information was reported: LYMPHADENOPATHY (non-serious) with onset 18Jul2021 08:15, outcome "not recovered", described as "Swollen Lymph Nodes - under arms, both sides"; BREAST TENDERNESS (non-serious) with onset 18Jul2021 08:15, outcome "not recovered", described as "Swollen Lymph Nodes - under arms, both sides, tender sides of breasts."; EOSINOPHIL COUNT INCREASED (non-serious) with onset 18Jul2021 08:15, outcome "not recovered", described as "CBC blood test showed doubled levels of absolute eosinophils". The events "swollen lymph nodes - under arms, both sides", "swollen lymph nodes - under arms, both sides, tender sides of breasts." and "cbc blood test showed doubled levels of absolute eosinophils" were evaluated at the physician office visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of lymphadenopathy, breast tenderness, eosinophil count increased.  Additional information: Swollen Lymph Nodes - under arms, both sides, tender sides of breasts. CBC blood test showed doubled levels of absolute eosinophils. Scheduled to follow up next week with new blood testing, recommended to get hematology consult, Ae treatment: Prescription strength anti-inflammatory drugs, if covid prior vaccination: No, if covid tested post vaccination: No, Known allergies: Tetracycline. Other medical history: Heart murmors  Follow-up attempts are completed. No further information is expected.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Pain in extremity
Clinical narrative: Sore arm; swollen lymph nodes in armpit and clavicle area; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non-HCP). The reporter is the patient. A 37-year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 16Aug2021 09:00 (Lot number: FA7485) at the age of 37 years as dose 2, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. Vaccination history included: Bnt162b2 (Product=COVID 19, brand=Pfizer, lot number=FA7484, lot unknown=False, administration time=09:00AM, vaccine location=Left arm, dose number=1), administration date: 26Jul2021, when the patient was 37 years old, for COVID-19 immunisation. The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 18Aug2021, outcome "not recovered", described as "Sore arm"; LYMPHADENOPATHY (non-serious) with onset 18Aug2021, outcome "not recovered", described as "swollen lymph nodes in armpit and clavicle area". Therapeutic measures were not taken as a result of pain in extremity, lymphadenopathy. Additional information The patient did not receive any other vaccine in four weeks. The patient did not receive any other medications in two weeks. The patient did not have any known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Adverse event: Sore arm and swollen lymph nodes in armpit and clavicle area,   No follow-up attempts are possible. No further information is expected.
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Fatigue, Headache, Lymphadenopathy, Oropharyngeal discomfort
Clinical narrative: Lymph nodes in my neck is swollen bad; my throat hurts; my throat hurts I can barely eat drink or talk.; My right under arm is swollen; I'm spitting up mucus; My head and and whole body hurts; whole body hurts; I'm weak and very tired; I'm weak and very tired; This is a spontaneous report received from contactable reporter(s) (Consumer or other non-HCP). The reporter is the patient.  A 22-year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 17Aug2021 15:30 (Lot number: FC3182) at the age of 22 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "allergies: Penicillin" (unspecified if ongoing). The patient concomitant medications were not reported. Vaccination history included: Bnt162b2 (vaccine location=Right arm, product=COVID 19, brand=Pfizer, lot number=EW0177, lot unknown=False, dose number=1, vaccine location=Right arm}]), administration date: 27Jul2021, when the patient was 22 years old, for covid-19 immunization. The following information was reported: LYMPHADENOPATHY (non-serious) with onset 17Aug2021 18:15, outcome "not recovered", described as "Lymph nodes in my neck is swollen bad"; OROPHARYNGEAL PAIN (non-serious) with onset 17Aug2021 18:15, outcome "not recovered", described as "my throat hurts"; OROPHARYNGEAL DISCOMFORT (non-serious) with onset 17Aug2021 18:15, outcome "not recovered", described as "my throat hurts I can barely eat drink or talk."; PERIPHERAL SWELLING (non-serious) with onset 17Aug2021 18:15, outcome "not recovered", described as "My right under arm is swollen"; SECRETION DISCHARGE (non-serious) with onset 17Aug2021 18:15, outcome "not recovered", described as "I'm spitting up mucus"; HEADACHE (non-serious) with onset 17Aug2021 18:15, outcome "not recovered", described as "My head and whole body hurts"; PAIN (non-serious) with onset 17Aug2021 18:15, outcome "not recovered", described as "whole body hurts"; ASTHENIA (non-serious), FATIGUE (non-serious) all with onset 17Aug2021 18:15, outcome "not recovered" and all described as "I'm weak and very tired". Therapeutic measures were not taken as a result of lymphadenopathy, oropharyngeal pain, oropharyngeal discomfort, peripheral swelling, secretion discharge, headache, pain, asthenia, fatigue.  Additional Information: The patient had other medical history: Severe allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient received 4 weeks of vaccination: yes. The patient did not receive other medications in two weeks. On 17Aug2021 at 06:15 PM the patient experienced adverse events. This has been going on for two days now. The patient was not received treatment with medications. The outcome of events was not recovered.  No follow-up attempts are possible. No further information is expected.
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Oropharyngeal pain, Pain, Peripheral swelling, Secretion discharge
Clinical narrative: Lymph nodes in my neck is swollen bad; my throat hurts; my throat hurts I can barely eat drink or talk.; My right under arm is swollen; I'm spitting up mucus; My head and and whole body hurts; whole body hurts; I'm weak and very tired; I'm weak and very tired; This is a spontaneous report received from contactable reporter(s) (Consumer or other non-HCP). The reporter is the patient.  A 22-year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 17Aug2021 15:30 (Lot number: FC3182) at the age of 22 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "allergies: Penicillin" (unspecified if ongoing). The patient concomitant medications were not reported. Vaccination history included: Bnt162b2 (vaccine location=Right arm, product=COVID 19, brand=Pfizer, lot number=EW0177, lot unknown=False, dose number=1, vaccine location=Right arm}]), administration date: 27Jul2021, when the patient was 22 years old, for covid-19 immunization. The following information was reported: LYMPHADENOPATHY (non-serious) with onset 17Aug2021 18:15, outcome "not recovered", described as "Lymph nodes in my neck is swollen bad"; OROPHARYNGEAL PAIN (non-serious) with onset 17Aug2021 18:15, outcome "not recovered", described as "my throat hurts"; OROPHARYNGEAL DISCOMFORT (non-serious) with onset 17Aug2021 18:15, outcome "not recovered", described as "my throat hurts I can barely eat drink or talk."; PERIPHERAL SWELLING (non-serious) with onset 17Aug2021 18:15, outcome "not recovered", described as "My right under arm is swollen"; SECRETION DISCHARGE (non-serious) with onset 17Aug2021 18:15, outcome "not recovered", described as "I'm spitting up mucus"; HEADACHE (non-serious) with onset 17Aug2021 18:15, outcome "not recovered", described as "My head and whole body hurts"; PAIN (non-serious) with onset 17Aug2021 18:15, outcome "not recovered", described as "whole body hurts"; ASTHENIA (non-serious), FATIGUE (non-serious) all with onset 17Aug2021 18:15, outcome "not recovered" and all described as "I'm weak and very tired". Therapeutic measures were not taken as a result of lymphadenopathy, oropharyngeal pain, oropharyngeal discomfort, peripheral swelling, secretion discharge, headache, pain, asthenia, fatigue.  Additional Information: The patient had other medical history: Severe allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient received 4 weeks of vaccination: yes. The patient did not receive other medications in two weeks. On 17Aug2021 at 06:15 PM the patient experienced adverse events. This has been going on for two days now. The patient was not received treatment with medications. The outcome of events was not recovered.  No follow-up attempts are possible. No further information is expected.